Taiko Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4574.T

Taiko Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending December 31, 2022: 21.41%

Taiko Pharmaceutical Co.,Ltd. Gross Profit Margin is 21.41% for the year ending December 31, 2022, a -16.45% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Taiko Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending December 31, 2021 was 25.62%, a -63.52% change year over year.
Taiko Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending December 31, 2020 was 70.24%, a -0.83% change year over year.
Taiko Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending March 31, 2020 was 70.82%, a 2.63% change year over year.
Taiko Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending March 31, 2019 was 69.01%, a -0.59% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Tokyo Stock Exchange: 4574.T

Taiko Pharmaceutical Co.,Ltd.

CEO	Mr. Takashi Shibata
IPO Date	March 18, 2009
Location	Japan
Headquarters	1-4-1, Nishi-Honmachi
Employees	208
Sector	Health Care
Industries Pharmaceuticals

Description

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`

Key trends

Past 5 years